お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
930600

デジタルセラピューティクス (DTx:Digital Therapeutics) の世界市場 ~2025年:境界型糖尿病・栄養・ケア・糖尿病・CVD・CNS・CRD・MSD・GI・薬物乱用・リハビリテーション

Digital Therapeutic (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel - Global forecasts to 2025

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 166 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.75円
デジタルセラピューティクス (DTx:Digital Therapeutics) の世界市場 ~2025年:境界型糖尿病・栄養・ケア・糖尿病・CVD・CNS・CRD・MSD・GI・薬物乱用・リハビリテーション
出版日: 2020年03月20日
発行: MarketsandMarkets
ページ情報: 英文 166 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のデジタルセラピューティクス (DTx:Digital Therapeutics) の市場は予測期間中26.7%のCAGRで推移し、2020年の21億米ドルから、2025年には69億米ドルの規模に成長すると予測されています。予防可能な慢性疾患の発生率の増加、医療費管理へのニーズ、DTxへの投資の拡大などの要因が同市場の成長を推進しています。しかし一方で、新興諸国におけるDTxプログラムへの認識およびアクセスの欠如、従来型の医療提供者からの抵抗、不安定な決済モデルなどの課題がさらなる成長の障壁となっています。用途別で見ると、治療・ケア用途が予防用途に勝るシェアを保持しており、医療費の上昇、慢性疾患の有病率の増加、DTxソリューションの高い費用効果などの要因が同部門の成長を牽引しています。対象疾患区分別では、糖尿病の部門が最大のシェアを占めています。糖尿病有病率の世界的増加、糖尿病の負担軽減に向けた政府の取り組みなどの要因が同部門の成長の要因となっています。地域別では、北米が最大かつもっとも急速に成長を遂げる地域市場となっています。DTxの新興企業の多さ、技術の進歩、DTxの償還構造の改善、DTxへの投資拡大を支援する政府のイニシアチブなどが同地域の高い成長に貢献しています。

当レポートでは、世界のデジタルセラピューティクス (DTx:Digital Therapeutics) の市場を調査し、市場の定義と概要、市場成長への各種影響因子および市場機会の分析、販売経路・用途・疾患区分・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 DTx市場の分析・予測:販売経路別

  • イントロダクション
  • B2B
    • 保険者
    • 雇用者
    • 製薬会社
    • 医療提供者
    • その他バイヤー
  • B2C
    • 介護者
    • 患者

第7章 DTx市場の分析・予測:用途別

  • イントロダクション
  • 治療・ケア用途
    • 糖尿病
    • 中枢神経系障害
    • 禁煙
    • 慢性呼吸器疾患
    • 筋骨格障害
    • 心血管疾患
    • 服薬遵守
    • 胃腸障害
    • リハビリ・患者ケア
    • 薬物乱用・依存症管理
    • その他
  • 予防的用途
    • 糖尿病
    • 肥満
    • 栄養
    • 生活習慣管理
    • その他

第8章 DTx市場の分析・予測:地域・主要国別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第9章 競合情勢

  • 概要
  • 企業ランキング
  • 競合リーダーシップマッピング
  • 競争状況・動向

第10章 企業プロファイル

  • NOOM
  • LIVONGO HEALTH
  • OMADA HEALTH
  • COGNIFIT
  • PROTEUS DIGITAL HEALTH
  • WELLDOC
  • GINGER
  • PROPELLER HEALTH
  • 2MORROW
  • CANARY HEALTH
  • MANGO HEALTH INC.
  • CLICK THERAPEUTICS
  • PEAR THERAPEUTICS
  • AKILI INTERACTIVE LABS
  • WELLTHY THERAPEUTICS
  • COGNOA
  • HAPPIFY
  • KAIA HEALTH
  • AYOGO HEALTH
  • BETTER THERAPEUTICS
  • MINDSTRONG HEALTH

第11章 付録

図表

LIST OF TABLES

  • TABLE 1: FACTOR ANALYSIS
  • TABLE 2: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 3: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 4: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 5: DIGITAL THERAPEUTICS MARKET FOR PAYERS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 6: DIGITAL THERAPEUTICS MARKET FOR EMPLOYERS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 7: DIGITAL THERAPEUTICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 8: DIGITAL THERAPEUTICS MARKET FOR PROVIDERS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 9: DIGITAL THERAPEUTICS MARKET FOR OTHER BUYERS, BY REGION, 018-2025 (USD MILLION)
  • TABLE 10: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 11: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 12: DIGITAL THERAPEUTICS MARKET FOR CAREGIVERS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 13: DIGITAL THERAPEUTICS MARKET FOR PATIENTS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 14: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 15: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 16: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 17: DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 18: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 19: DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 20: DIGITAL THERAPEUTICS MARKET FOR CHRONIC RESPIRATORY DISEASES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 21: DIGITAL THERAPEUTICS MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 22: DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 23: DIGITAL THERAPEUTICS MARKET FOR MEDICATION ADHERENCE, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 24: DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 25: DIGITAL THERAPEUTICS MARKET FOR REHABILITATION & PATIENT CARE, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 26: DIGITAL THERAPEUTICS MARKET FOR SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 27: DIGITAL THERAPEUTICS MARKET FOR OTHER TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 28: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 29: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 30: DIGITAL THERAPEUTICS MARKET FOR PREDIABETES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 31: DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 32: DIGITAL THERAPEUTICS MARKET FOR NUTRITION, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 33: DIGITAL THERAPEUTICS MARKET FOR LIFESTYLE MANAGEMENT, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 34: DIGITAL THERAPEUTICS MARKET FOR OTHER PREVENTIVE APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 35: DIGITAL THERAPEUTICS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 36: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 37: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 38: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 39: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 40: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 41: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 42: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 43: US: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 44: US: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 45: US: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 46: US: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 47: US: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 48: US: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 49: CANADA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 50: CANADA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 51: CANADA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 52: CANADA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 53: CANADA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 54: CANADA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 55: EUROPE: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 56: EUROPE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 57: EUROPE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 58: EUROPE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 59: EUROPE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 60: EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 61: EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 62: GERMANY: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 63: GERMANY: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 64: GERMANY: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 65: GERMANY: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 66: GERMANY: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 67: GERMANY: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 68: UK: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 69: UK: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 70: UK: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 71: UK: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 72: UK: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 73: UK: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 74: FRANCE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 75: FRANCE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 76: FRANCE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 77: FRANCE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 78: FRANCE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 79: FRANCE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 80: SPAIN: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 81: SPAIN: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 82: SPAIN: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 83: SPAIN: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 84: SPAIN: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 85: SPAIN: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 86: ITALY: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 87: ITALY: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 88: ITALY: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 89: ITALY: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 90: ITALY: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 91: ITALY: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 92: ROE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 93: ROE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 94: ROE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 95: ROE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 96: ROE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 97: ROE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 98: APAC: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 99: APAC: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 100: APAC: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 101: APAC: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 102: APAC: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 103: APAC: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 104: APAC: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 105: JAPAN: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 106: JAPAN: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 107: JAPAN: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 108: JAPAN: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 109: JAPAN: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 110: JAPAN: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 111: CHINA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 112: CHINA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 113: CHINA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 114: CHINA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 115: CHINA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 116: CHINA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 117: INDIA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 118: INDIA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 119: INDIA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 120: INDIA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 121: INDIA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 122: INDIA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 123: ROAPAC: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 124: ROAPAC: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 125: ROAPAC: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 126: ROAPAC: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 127: ROAPAC: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 128: ROAPAC: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 129: ROW: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 130: ROW: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 131: ROW: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 132: ROW: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018-2025 (USD MILLION)
  • TABLE 133: ROW: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)
  • TABLE 134: ROW: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018-2025 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: PRIMARY SOURCES
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY TYPE OF BUYER AND REGION
  • FIGURE 5: ESTIMATION OF THE DIGITAL THERAPEUTICS MARKET: REVENUE MAPPING-BASED ESTIMATION
  • FIGURE 6: MARKET SIZE ESTIMATION: BUYER ADOPTION-BASED
  • FIGURE 7: PENETRATION RATE-BASED MARKET ESTIMATION
  • FIGURE 8: DATA TRIANGULATION METHODOLOGY
  • FIGURE 9: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020 VS. 2025 (USD MILLION)
  • FIGURE 10: CAREGIVERS SEGMENT TO REGISTER SIGNIFICANT GROWTH DURING THE FORECAST PERIOD
  • FIGURE 11: PAYERS TO DOMINATE THE DIGITAL THERAPEUTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 12: DIGITAL THERAPEUTICS MARKET, BY APPLICATION (2020-2025)
  • FIGURE 13: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS (2020-2025)
  • FIGURE 14: GEOGRAPHICAL SNAPSHOT OF THE DIGITAL THERAPEUTICS MARKET
  • FIGURE 15: INCREASING INCIDENCE OF CHRONIC DISEASES & TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE ADOPTION OF DIGITAL THERAPEUTICS
  • FIGURE 16: B2B SALES DOMINATE THE DIGITAL THERAPEUTICS MARKET
  • FIGURE 17: PAYERS HELD THE LARGEST SHARE OF THE MARKET, BY B2B SALES CHANNEL, IN 2019
  • FIGURE 18: NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR DIGITAL THERAPEUTICS
  • FIGURE 19: DIGITAL THERAPEUTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SNAPSHOT
  • FIGURE 21: EUROPE: DIGITAL THERAPEUTICS MARKET SNAPSHOT
  • FIGURE 22: KEY DEVELOPMENTS IN THE DIGITAL THERAPEUTICS MARKET
  • FIGURE 23: DIGITAL THERAPEUTICS MARKET RANKING ANALYSIS, 2019
  • FIGURE 24: DIGITAL THERAPEUTICS (DTX) MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
目次
Product Code: HIT 4407

"Growing incidence of preventable chronic diseases and the need to control healthcare costs are the key factors driving the growth of the digital therapeutics market."

The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period. Growth in this market is mainly driven by the growing incidence of preventable chronic diseases, the need to control healthcare costs, and rising investments in digital therapeutics. On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, resistance from traditional healthcare providers, and unstable payment models are challenging the growth of this market.

Treatment/care-related applications segment accounted for the largest share of the digital therapeutics market in 2019

Based on application, the digital therapeutics market is segmented into preventive and treatment/care-related applications. Rising healthcare costs, the growing prevalence of chronic diseases, and the ability of digital therapeutics to provide cost-effective solutions are some factors responsible for driving the market for treatment/care-related digital therapeutics applications.

Diabetes segment is expected to dominate the market

Based on the type of treatment/care-related application, the digital therapeutics market is further segmented into diabetes, CNS disorders, chronic respiratory diseases, musculoskeletal disorders, cardiovascular diseases, smoking cessation, medication adherence, gastrointestinal disorders, substance use disorders & addiction management, rehabilitation & patient care, and other treatment/care-related applications. The diabetes segment accounted for the largest share of the digital therapeutics market. The large share of this segment is attributed to the growing prevalence of diabetes across the globe. In addition, government initiatives to reduce the burden of diabetes using digital health are responsible for the large share of this segment.

B2B segment is expected to grow at the highest CAGR during the forecast period.

Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B). The B2B segment is the largest and fastest-growing segment of the digital therapeutics market. The high preference of pharmaceutical companies to integrate digital therapeutics with their drug products to offer adherence services is a key factor driving the growth of this segment. Furthermore, rising awareness among payers, employers, and providers about the benefits of digital therapeutics has also supported the market growth.

North America to be the largest and the fastest-growing regional market

North America, which comprises the US and Canada, forms the largest market for digital therapeutics. The US is home to a plethora of digital therapeutics start-ups. In addition, government initiatives to support technological advancements, improvements in the reimbursement structure for digital therapeutics, and the increasing investments in digital therapeutics are responsible for the high growth of digital therapeutics in North America.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 (50%), Tier 2 (30%), and Tier 3 (20%)
  • By Designation: C-level (75%), D-level (15%), and Others (10%)
  • By Region: North America (70%), Europe (20%), APAC (7%), and the RoW (3%)

List of Companies Profiled in the Report:

  • Noom (US)
  • Livongo Health (US)
  • Omada Health (US)
  • WellDoc (US)
  • Pear Therapeutics (US)
  • Proteus Digital Health (US)
  • Propeller Health (US)
  • Akili Interactive Labs (US)
  • Better Therapeutics (US)
  • Happify (US)
  • Kaia Health (Germany)
  • Mango Health (US)
  • Click Therapeutics (US)
  • Canary Health (US)
  • Wellthy Therapeutics (India)
  • Cognoa (US)
  • Ayogo Health (Canada)
  • Mindstrong Health (US)
  • 2Morrow (US)
  • Ginger (US)

Research Coverage:

This report provides a study of the digital therapeutics market. It aims at estimating the size and future growth potential of the market across different segments, such as sales channel, application, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of revenue numbers for the overall digital therapeutics market and its subsegments. This report will also help stakeholders understand the competitive landscape, gain insights to position their business, and make suitable go-to-market strategies. It will also enable stakeholders to gauge the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 MARKETS COVERED
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach one: revenue mapping-based estimation
      • 2.2.1.2 Approach two: buyer adoption-based estimation
    • 2.2.2 TOP-DOWN APPROACH: PENETRATION RATE-BASED MARKET SIZE ESTIMATION
    • 2.2.3 GROWTH FORECAST
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET PLAYER RANKING
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 DIGITAL THERAPEUTICS MARKET OVERVIEW
  • 4.2 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020-2025
  • 4.3 B2B SALES CHANNEL MARKET SHARE, BY BUYER & REGION (2019)
  • 4.4 DIGITAL THERAPEUTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of preventable chronic diseases
      • 5.2.1.2 Rising focus on preventive healthcare
      • 5.2.1.3 Need to control healthcare costs
      • 5.2.1.4 Significant increase in venture capital investments
      • 5.2.1.5 Benefits of digital therapeutics
        • 5.2.1.5.1 Ability to induce behavioral change
        • 5.2.1.5.2 Improved drug adherence
        • 5.2.1.5.3 Patient convenience and user-friendliness
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Patient data privacy concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets
      • 5.2.3.2 Large undiagnosed and untreated population
      • 5.2.3.3 Unexplored therapeutic applications
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Unstable payment models
      • 5.2.4.2 Reluctance among patients to adopt digital therapeutics
      • 5.2.4.3 Lack of awareness and access to digital therapeutics programs in developing countries
      • 5.2.4.4 Resistance from traditional healthcare providers

6 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL

  • 6.1 INTRODUCTION
  • 6.2 B2B
    • 6.2.1 PAYERS
      • 6.2.1.1 Payers hold the highest share of the market, by B2B sales
    • 6.2.2 EMPLOYERS
      • 6.2.2.1 Importance of employee health management is propelling the adoption of digital therapeutics among employers
    • 6.2.3 PHARMACEUTICAL COMPANIES
      • 6.2.3.1 Cross-industry collaboration between digital therapeutics start-ups and pharmaceutical companies will drive market growth
    • 6.2.4 PROVIDERS
      • 6.2.4.1 Potential for better patient management and cost-reductions are driving demand for digital therapeutics among providers
    • 6.2.5 OTHER BUYERS
  • 6.3 B2C
    • 6.3.1 CAREGIVERS
      • 6.3.1.1 Ease of managing health conditions has driven demand for solutions among caregivers
    • 6.3.2 PATIENTS
      • 6.3.2.1 Awareness about preventive health among patients will drive the growth of this segment

7 DIGITAL THERAPEUTICS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 TREATMENT/CARE-RELATED APPLICATIONS
    • 7.2.1 DIABETES
      • 7.2.1.1 Growing prevalence of diabetes drives market growth
    • 7.2.2 CENTRAL NERVOUS SYSTEM DISORDERS
      • 7.2.2.1 Potential benefits of digital therapeutics in CNS disorder management have driven the development of solutions
    • 7.2.3 SMOKING CESSATION
      • 7.2.3.1 Focus on providing clinically validated, effective mobile applications to help quit smoking drives market growth
    • 7.2.4 CHRONIC RESPIRATORY DISEASES
      • 7.2.4.1 Growing prevalence of COPD and asthma is responsible for market growth in this segment
    • 7.2.5 MUSCULOSKELETAL DISORDERS
      • 7.2.5.1 Potential of digital therapeutics in pain management to drive the adoption of these solutions among end users
    • 7.2.6 CARDIOVASCULAR DISEASES
      • 7.2.6.1 Increasing costs of care drive the need for digital therapeutics solutions
    • 7.2.7 MEDICATION ADHERENCE
      • 7.2.7.1 Need to drive medication adherence rates has propelled the demand for effective solutions
    • 7.2.8 GASTROINTESTINAL DISORDERS
      • 7.2.8.1 Availability of mobile applications for the management of GI conditions to drive the market growth
    • 7.2.9 REHABILITATION & PATIENT CARE
      • 7.2.9.1 Benefits of digital therapeutics have induced startups to develop platforms for patient care
    • 7.2.10 SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT
      • 7.2.10.1 Potential to improve the efficiency of behavioral interventions are encouraging market growth
    • 7.2.11 OTHER TREATMENT/CARE-RELATED APPLICATIONS
  • 7.3 PREVENTIVE APPLICATIONS
    • 7.3.1 PREDIABETES
      • 7.3.1.1 Influx of startups to provide effective prevention against prediabetes drives the growth of this segment
    • 7.3.2 OBESITY
      • 7.3.2.1 Availability of cost-effective solutions for obesity management propels the growth of this segment
    • 7.3.3 NUTRITION
      • 7.3.3.1 Importance of nutrition in preventing a wide range of ailments has driven demand for digital therapeutic solutions
    • 7.3.4 LIFESTYLE MANAGEMENT
      • 7.3.4.1 Ability of digital therapeutics solutions to induce positive behavioral changes has contributed to the rise in demand
    • 7.3.5 OTHER PREVENTIVE APPLICATIONS

8 DIGITAL THERAPEUTICS MARKET, BY REGION

  • 8.1 INTRODUCTION
  • 8.2 NORTH AMERICA
    • 8.2.1 US
      • 8.2.1.1 Major digital therapeutics start-ups are based out of the US, which has greatly supported access to solutions
    • 8.2.2 CANADA
      • 8.2.2.1 Efforts are being taken by the Canadian government to support digital therapeutics
  • 8.3 EUROPE
    • 8.3.1 GERMANY
      • 8.3.1.1 Germany accounted for the largest share of the digital therapeutics market in Europe
    • 8.3.2 UK
      • 8.3.2.1 Well-established healthcare system and government support will propel the growth of the market
    • 8.3.3 FRANCE
      • 8.3.3.1 Growing healthcare expenditure and favorable health insurance system to support market growth in France
    • 8.3.4 SPAIN
      • 8.3.4.1 Initiatives by emerging digital therapeutics startups are supporting market growth
    • 8.3.5 ITALY
      • 8.3.5.1 Need for alternative and effective treatment to drive the market growth in the coming years
    • 8.3.6 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 JAPAN
      • 8.4.1.1 Rising diabetes incidence and collaborations between stakeholders are indicators of market growth in Japan
    • 8.4.2 CHINA
      • 8.4.2.1 Growing geriatric population and incidence of chronic conditions will drive demand for digital therapeutics in China
    • 8.4.3 INDIA
      • 8.4.3.1 Rising chronic disease incidence and the need for better disease management drive market growth
    • 8.4.4 REST OF APAC
  • 8.5 REST OF THE WORLD

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 MARKET RANKING ANALYSIS, 2019
  • 9.3 COMPETITIVE LEADERSHIP MAPPING
    • 9.3.1 VISIONARY LEADERS
    • 9.3.2 DYNAMIC DIFFERENTIATORS
    • 9.3.3 INNOVATORS
    • 9.3.4 EMERGING COMPANIES
  • 9.4 COMPETITIVE SITUATION AND TRENDS
    • 9.4.1 PRODUCT LAUNCHES
    • 9.4.2 EXPANSIONS
    • 9.4.3 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS

10 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 10.1 NOOM
  • 10.2 LIVONGO HEALTH
  • 10.3 OMADA HEALTH
  • 10.4 COGNIFIT
  • 10.5 PROTEUS DIGITAL HEALTH
  • 10.6 WELLDOC
  • 10.7 GINGER
  • 10.8 PROPELLER HEALTH
  • 10.9 2MORROW
  • 10.10 CANARY HEALTH
  • 10.11 MANGO HEALTH INC.
  • 10.12 CLICK THERAPEUTICS
  • 10.13 PEAR THERAPEUTICS
  • 10.14 AKILI INTERACTIVE LABS
  • 10.15 WELLTHY THERAPEUTICS
  • 10.16 COGNOA
  • 10.17 HAPPIFY
  • 10.18 KAIA HEALTH
  • 10.19 AYOGO HEALTH
  • 10.20 BETTER THERAPEUTICS
  • 10.21 MINDSTRONG HEALTH

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

11 APPENDIX

  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3 AVAILABLE CUSTOMIZATIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.